Indicators

Markets:

News

Market Indicators

Chart for State Street SPDR Dow Jones Industrial Average ETF Trust (NY: DIA)

Name	Price	Change	% Change
DJIA ETF	524.76	+0.32	+0.06%
S&P ETF	759.31	-0.50	-0.07%
QQQ	689.34	-1.04	-0.15%
Gold RT	3,885.70	-114.80	-2.87%
Oil RT	88.15	+1.62	+1.87%
Bitcoin RT	71,462.26	-2389.85	-3.24%

World Markets

Index		Price	Change	% Change
	FTSE	10,835.47	+83.88	+0.78%
	CAC	8,273.84	+0.00	0.00%
	NIKKEI	61,248.59	+0.00	0.00%
	HSI	24,315.92	+0.00	0.00%
	S&P/TSX	36,226.54	-185.18	-0.51%

Sector ETFs

Sector	% Change	YTD %
Basic Materials	-1.01%	+16.51%
Consumer Goods	+0.14%	+19.49%
Energy	+1.99%	+40.72%
Financial Services	-0.18%	+5.00%
Healthcare	-0.30%	+20.81%
Industrial	-0.39%	+7.36%
Technology	-0.51%	+17.81%
Telecom	+0.35%	+18.06%
Utilities	+0.43%	+2.90%

Market News

News headline image

Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping ↗

Today 14:00 EST

News headline image

Democrats Win Sweeping Control of Congress. Here's 1 Cryptocurrency to Buy and 1 Cryptocurrency to Sell. ↗

Today 13:55 EST

Via The Motley Fool

News headline image

Why Corteva Stock Dropped on Thursday ↗

Today 13:51 EST

Via The Motley Fool

News headline image

PROG Holdings: 3 Key Takeaways for Long-Term Investors ↗

Today 13:50 EST

Via The Motley Fool

Avalyn Pharma Inc (NASDAQ:AVLN) Q3 Loss Narrower Than Expected as 2027 Pipeline Catalysts Remain in Focus ↗

Today 12:22 EST

Currencies

More Currencies

▼ -0.36% today

▼ -0.35% today

▲ +0.03% today

▲ +0.04% today

More News

News headline image

PROG Holdings: 3 Key Takeaways for Long-Term Investors ↗

Today 13:50 EST

The Four unit's 30.6% margin shows the company can scale rapidly without sacrificing profitability.

Via The Motley Fool

Avalyn Pharma Inc (NASDAQ:AVLN) Q3 Loss Narrower Than Expected as 2027 Pipeline Catalysts Remain in Focus ↗

Today 12:22 EST

Aktis Oncology (NASDAQ:AKTS) Q3 2026 Results Miss Estimates as Costs Rise ↗

Today 12:21 EST

News headline image

The S&P 500 Is Hiding a Sneaky Risk. Here's How Investors Can Prepare for Potential Volatility. ↗

Today 13:50 EST

There's more to this popular benchmark than meets the eye.

Via The Motley Fool

News headline image

Bit Digital (BTBT) Q3 2026 Earnings Call Transcript ↗

Today 13:46 EST

Revenue is shifting toward staking and AI infrastructure as buybacks come into view.

Via The Motley Fool

News headline image

Jensen Huang Is Out as Nvidia Names Colette Kress Interim CEO ↗

Today 13:46 EST

CFO Colette Kress is now interim CEO while the board weighs whether a finance background is the right fit.

Via The Motley Fool

Vivani Medical (NASDAQ:VANI) Jumps on Positive SLIM-1 Phase 1 Data Despite Pre-Revenue Q3 ↗

Today 12:20 EST

News headline image

EZCORP (EZPW) Q4 2026 Earnings Call Transcript ↗

Today 13:36 EST

Latin American labor costs and store integration timing are the watch points.

Via The Motley Fool

News headline image

Nvidia CEO Jensen Huang Says AI's 'Most Profound Impact' Will Be in Life Sciences -- and Eli Lilly Is Already Building on It ↗

Today 13:36 EST

The world's largest healthcare company is making shrewd investments in its future.

Via The Motley Fool

News headline image

Beachbody: 3 Key Takeaways for Long-Term Investors ↗

Today 13:35 EST

Retail shelves reset only once or twice a year, so Beachbody's expansion timeline rests on store schedules it cannot control.

Via The Motley Fool

News headline image

Lufax: 3 Key Takeaways for Long-Term Investors ↗

Today 13:35 EST

Regulatory headwinds forced higher credit provisions, but an internal collection team now shields Lufax from vendor constraints competitors face.

Via The Motley Fool

News headline image

What Went Wrong With Amprius Technologies' Q3? Less Than You'd Think ↗

Today 13:25 EST

Amprius Technologies posted 83% revenue growth in Q3, raised guidance, and improved margins and cash position, despite a narrow EPS miss, as analysts maintain a bullish outlook on AMPX.

News headline image

Ocugen Eyes 2027 Trial Results and FDA Filing for Lead Gene Therapy ↗

Today 13:14 EST

Ocugen (NASDAQ:OCGN) expects pivotal data for its lead experimental gene therapy for retinitis pigmentosa in the first quarter of 2027, a milestone that could set up a regulatory filing later that...

News headline image

Nexxen International Q3 Earnings Call Highlights ↗

Today 13:14 EST

Nexxen International (NASDAQ:NEXN) reported record third-quarter Contribution ex-TAC and programmatic revenue, as connected TV and enterprise customer growth helped offset declines in desktop and...

News headline image

What MediWound (MDWD) Said on Its Q3 Earnings Call ↗

Today 13:14 EST

MediWound (NASDAQ:MDWD) reported lower third-quarter revenue and a wider net loss as it increased spending on its late-stage EscharEx trial, while executives said manufacturing constraints continue to...

News headline image

What Broadwind Energy (BWEN) Said on Its Q3 Earnings Call ↗

Today 13:14 EST

Broadwind Energy (NASDAQ:BWEN) reported a 48% increase in third-quarter 2026 revenue as demand for power generation equipment and other industrial products helped lift orders and backlog. The company...

News headline image

What DeFi Development (DFDV) Said on Its Q3 Earnings Call ↗

Today 13:14 EST

DeFi Development (NASDAQ:DFDV) reported growth in its Solana-per-share measure and a stronger cash position for the third quarter, while executives said the launch of its CHAD preferred stock is...

News headline image

Figure Technology Solutions Q3 Earnings Call Highlights ↗

Today 13:14 EST

Figure Technology Solutions (NASDAQ:FIGR) reported a 135% increase in third-quarter loan marketplace volume and expanded its share repurchase authorization to $400 million as its acquisition of Kiavi...

News headline image

Fermi Q3 Earnings Call Highlights ↗

Today 13:14 EST

Fermi (NASDAQ:FRMI) said it reached agreements with an unnamed investment-grade hyperscaler for 600 megawatts of 2027 power capacity at its Project Matador campus in Texas, while a previously announced...

News headline image

What OHB (OHB) Said on Its Q3 Earnings Call ↗

Today 13:14 EST

OHB (ETR:OHB) confirmed its 2026 guidance after reporting higher operating performance and profitability for the first nine months of the year, as major satellite contracts expanded its order book and...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.